Ebselen and Diphenyl Diselenide Inhibit SARS-CoV-2 Replication at Non-Toxic Concentrations to Human Cell Lines

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the causative agent of the COVID-19 pandemic, a global public health problem. Despite the numerous studies for drug repurposing, there are only two FDA-approved antiviral agents (Remdesivir and Nirmatrelvir) for non-hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales: Wildner, Guilherme, Tucci, Amanda Resende, Prestes, Alessandro de Souza, Muller, Talise, Rosa, Alice dos Santos, Borba, Nathalia Roberto R., Ferreira, Vivian Neuza, Rocha, João Batista Teixeira, Miranda, Milene Dias, Barbosa, Nilda Vargas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384302/
https://www.ncbi.nlm.nih.gov/pubmed/37515038
http://dx.doi.org/10.3390/vaccines11071222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384302/
https://www.ncbi.nlm.nih.gov/pubmed/37515038
http://dx.doi.org/10.3390/vaccines11071222

Ejemplares similares